Thassu, Deepak
Nanoparticulate drug delivery systmes - 1st - New York 2007 - x, 352 Pages | Binding - Card Paper |
With the advent of analytical techniques and capabilities to measure particle sizes in nanometer ranges, there has been tremendous interest in the use of nanoparticles for more efficient methods of drug delivery. Nanoparticulate Drug Delivery Systems addresses the scientific methodologies, formulation, processing, applications, recent trends, and emerging technologies in the research of nanoparticulate drug delivery systems (NPDDS). It extensively covers applications of NPDDS— including lipid nanoparticles for dermal applications; nanocarriers for the treatment of restenosis; and for ocular, central nervous system, and gastrointestinal applications. It also explores its use as an adjuvant for vaccine development.
Supplying insight from international experts, this guide
Discusses formulation for poorly soluble drugs
Presents biological requirements for nanotherapeutic applications
Demonstrates the role of nanobiotechnology in the development of nanomedicine
Documents recent advances in nanoparticulate technology—including electrospining, formation of microcrystals, and production of liquid crystalline phases
Examines the technology of metallic nanoparticles
0-8493-9073-7
PHARMACEUTICS
NANOPARTICULATEDRUG-DELIVERYSYSTEMS; NANOSUSPENSIONSFORPARENTERALDELIVERY; NANOPARTICLESPREPAREDUSINGNATURAL ANDSYNTHETICPOLYMERS
615 / THA/DEL
Nanoparticulate drug delivery systmes - 1st - New York 2007 - x, 352 Pages | Binding - Card Paper |
With the advent of analytical techniques and capabilities to measure particle sizes in nanometer ranges, there has been tremendous interest in the use of nanoparticles for more efficient methods of drug delivery. Nanoparticulate Drug Delivery Systems addresses the scientific methodologies, formulation, processing, applications, recent trends, and emerging technologies in the research of nanoparticulate drug delivery systems (NPDDS). It extensively covers applications of NPDDS— including lipid nanoparticles for dermal applications; nanocarriers for the treatment of restenosis; and for ocular, central nervous system, and gastrointestinal applications. It also explores its use as an adjuvant for vaccine development.
Supplying insight from international experts, this guide
Discusses formulation for poorly soluble drugs
Presents biological requirements for nanotherapeutic applications
Demonstrates the role of nanobiotechnology in the development of nanomedicine
Documents recent advances in nanoparticulate technology—including electrospining, formation of microcrystals, and production of liquid crystalline phases
Examines the technology of metallic nanoparticles
0-8493-9073-7
PHARMACEUTICS
NANOPARTICULATEDRUG-DELIVERYSYSTEMS; NANOSUSPENSIONSFORPARENTERALDELIVERY; NANOPARTICLESPREPAREDUSINGNATURAL ANDSYNTHETICPOLYMERS
615 / THA/DEL